Correlation Between DiaMedica Therapeutics and Alumis Common
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Alumis Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Alumis Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Alumis Common Stock, you can compare the effects of market volatilities on DiaMedica Therapeutics and Alumis Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Alumis Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Alumis Common.
Diversification Opportunities for DiaMedica Therapeutics and Alumis Common
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between DiaMedica and Alumis is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Alumis Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alumis Common Stock and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Alumis Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alumis Common Stock has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Alumis Common go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Alumis Common
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.03 times more return on investment than Alumis Common. However, DiaMedica Therapeutics is 1.03 times more volatile than Alumis Common Stock. It trades about 0.12 of its potential returns per unit of risk. Alumis Common Stock is currently generating about -0.06 per unit of risk. If you would invest 295.00 in DiaMedica Therapeutics on September 26, 2024 and sell it today you would earn a total of 231.00 from holding DiaMedica Therapeutics or generate 78.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Alumis Common Stock
Performance |
Timeline |
DiaMedica Therapeutics |
Alumis Common Stock |
DiaMedica Therapeutics and Alumis Common Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Alumis Common
The main advantage of trading using opposite DiaMedica Therapeutics and Alumis Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Alumis Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alumis Common will offset losses from the drop in Alumis Common's long position.DiaMedica Therapeutics vs. Fate Therapeutics | DiaMedica Therapeutics vs. Caribou Biosciences | DiaMedica Therapeutics vs. Karyopharm Therapeutics | DiaMedica Therapeutics vs. Hookipa Pharma |
Alumis Common vs. FTAI Aviation Ltd | Alumis Common vs. United Rentals | Alumis Common vs. Willscot Mobile Mini | Alumis Common vs. Triton International Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world |